155 related articles for article (PubMed ID: 34874278)
1. Synoviolin inhibits the inflammatory cytokine secretion of Müller cells by reducing NLRP3.
Zhang J; Chen C; Wu L; Wang Q; Chen J; Zhang S; Chen Z
J Mol Endocrinol; 2022 Jan; 68(2):125-136. PubMed ID: 34874278
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis.
Li W; Liu X; Tu Y; Ding D; Yi Q; Sun X; Wang Y; Wang K; Zhu M; Mao J
Neuropeptides; 2020 Aug; 82():102057. PubMed ID: 32461025
[TBL] [Abstract][Full Text] [Related]
3. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells.
Du J; Wang Y; Tu Y; Guo Y; Sun X; Xu X; Liu X; Wang L; Qin X; Zhu M; Song E
Exp Eye Res; 2020 Jul; 196():108065. PubMed ID: 32407725
[TBL] [Abstract][Full Text] [Related]
4. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination.
Rao Z; Chen X; Wu J; Xiao M; Zhang J; Wang B; Fang L; Zhang H; Wang X; Yang S; Chen Y
Front Immunol; 2019; 10():2783. PubMed ID: 31866999
[TBL] [Abstract][Full Text] [Related]
6. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
7. miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis.
Scalavino V; Piccinno E; Valentini AM; Schena N; Armentano R; Giannelli G; Serino G
Cells; 2023 Aug; 12(17):. PubMed ID: 37681916
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
9. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in
Yalcinkaya M; Liu W; Thomas LA; Olszewska M; Xiao T; Abramowicz S; Papapetrou EP; Westerterp M; Wang N; Tabas I; Tall AR
Circulation; 2023 Nov; 148(22):1764-1777. PubMed ID: 37781816
[TBL] [Abstract][Full Text] [Related]
10. PD protects Müller cells through the SIRT1/NLRP3 inflammasome pathway.
Wang B; Qu X; Su A; Zhu H
Int Ophthalmol; 2024 Feb; 44(1):97. PubMed ID: 38372810
[TBL] [Abstract][Full Text] [Related]
11. BC-1215 inhibits ATP-induced IL-1β secretion via the FBXL2-mediated ubiquitination and degradation of not only NLRP3, but also pro-IL-1β in LPS-primed THP-1 cells.
Jeon S; Kang J; Lee SB
Biochem Biophys Res Commun; 2023 May; 657():128-135. PubMed ID: 37004285
[TBL] [Abstract][Full Text] [Related]
12. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis.
Hu J; Wu H; Wang D; Yang Z; Dong J
Biochimie; 2019 Feb; 157():102-110. PubMed ID: 30347231
[TBL] [Abstract][Full Text] [Related]
15. The BRCC3 regulated by Cdk5 promotes the activation of neuronal NLRP3 inflammasome in Parkinson's disease models.
Cheng X; Xu S; Zhang C; Qin K; Yan J; Shao X
Biochem Biophys Res Commun; 2020 Feb; 522(3):647-654. PubMed ID: 31787240
[TBL] [Abstract][Full Text] [Related]
16. LncRNA XIST restrains the activation of Müller cells and inflammation in diabetic retinopathy via stabilizing SIRT1.
Zhang J; Chen C; Zhang S; Chen J; Wu L; Chen Z
Autoimmunity; 2021 Dec; 54(8):504-513. PubMed ID: 34498499
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
Py BF; Kim MS; Vakifahmetoglu-Norberg H; Yuan J
Mol Cell; 2013 Jan; 49(2):331-8. PubMed ID: 23246432
[TBL] [Abstract][Full Text] [Related]
18. ABRO1 stabilizes the deubiquitinase BRCC3 through inhibiting its degradation mediated by the E3 ubiquitin ligase WWP2.
Zhang W; Tao SS; Wang T; Zhang J; Liu X; Li YT; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Ren GM; Yang XM; Yin RH
FEBS Lett; 2021 Jan; 595(2):169-182. PubMed ID: 33107021
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation.
Li S; Yang H; Chen X
Exp Anim; 2019 May; 68(2):221-231. PubMed ID: 30606939
[TBL] [Abstract][Full Text] [Related]
20. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
Front Immunol; 2021; 12():741839. PubMed ID: 34512673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
